Phase I Study of PD-L1 Inhibition With Avelumab and Laser Interstitial Thermal Therapy in Patients With Recurrent Glioblastoma
Phase of Trial: Phase I
Latest Information Update: 19 Jul 2018
At a glance
- Drugs Avelumab (Primary)
- Indications Glioblastoma
- Focus Adverse reactions; Therapeutic Use
- 11 Jul 2018 Status changed from not yet recruiting to recruiting.
- 21 Mar 2018 Planned initiation date changed from 1 Feb 2018 to 1 Jun 2018.
- 04 Jan 2018 Planned initiation date changed from 30 Nov 2017 to 1 Feb 2018.